graph digitizer software (GetData Pty Ltd)
90
Structured Review
GetData Pty Ltd
graph digitizer software
Graph Digitizer Software, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scatter+plot+graph/graph+digitizer+software/pmc09707831-66-9-8
Average 90 stars, based on 1 article reviews
Graph Digitizer Software, supplied by GetData Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scatter+plot+graph/graph+digitizer+software/pmc09707831-66-9-8
Average 90 stars, based on 1 article reviews
graph digitizer software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Quantifying microbial necromass contributions to soil carbon sequestration under diverse cropland management practices: A meta-analysis. Article Snippet: Under the dual challenges of global climate change and agricultural sustainability, cropland soils, as critical carbon (C) sinks, have garnered significant attention regarding the stabilization mechanisms of their organic C pools.. Existing studies indicate that the stable organic C pool in cropland soils primarily originates from the accumulation of microbial necromass, a process strongly influence by agricultural management practices.. However, there remains a notable knowledge gap regarding how various management strategies influence microbially turnover and necromass formation mechanisms. Article Title: Cost-effectiveness analysis of adding transarterial chemoembolization to lenvatinib as first-line treatment for advanced hepatocellular carcinoma in China Article Snippet: .. The PFS and OS data were extracted from the published K-M curves by using Article Title: Pembrolizumab plus chemotherapy in advanced endometrial cancer: a cost-effectiveness analysis. Article Snippet: .. First, Article Title: Trastuzumab Deruxtecan and Sacituzumab Govitecan for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Low Metastatic Breast Cancer: A Cost-Effectiveness Analysis. Article Snippet: Objective: We aim to analyze the pharmacoeconomic characteristics of trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in the treatment of patients with hormone receptor-positive (HR + ) and human epidermal growth factor receptor 2-low (HER2-low) metastatic breast cancer who have previously undergone chemotherapy.. Methods: A cost-effectiveness study was conducted to compare these two treatment options with chemotherapy, respectively, in terms of their economic impact and clinical outcomes from the perspective of the United States payer.. A partitioned survival model with a lifetime horizon comprising three distinct states was utilized for the simulation process of patients receiving trastuzumab deruxtecan or sacituzumab govitecan (in the T-DXd or SG group, respectively). Article Title: Toripalimab plus chemotherapy versus chemotherapy as first-line therapy for extensive-stage small cell lung cancer: a cost-effectiveness analysis Article Snippet: .. The survival curves of the trials were then extracted using the Article Title: Pembrolizumab plus chemotherapy in advanced endometrial cancer: a cost-effectiveness analysis Article Snippet: .. First, Article Title: Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence. Article Snippet: .. For studies requiring data extraction from graphical representations, Article Title: First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis Article Snippet: .. Survival data were digitized from the JUPITER-06 survival curves using the Get Extraction:Article Title: Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence. Article Snippet: .. For studies requiring data extraction from graphical representations, |